10 ENGLISH BOOKS RELATING TO «REOVIRUS»
Discover the use of
reovirus in the following bibliographical selection. Books relating to
reovirus and brief extracts from same to provide context of its use in English literature.
1
Cellular Targets Involved in
Reovirus-induced Oncolysis of ...
Reovirus is a ubiquitous virus with demonstrated oncolytic properties.
2
Cardiac Cell Type-specific Differences in the Interferon ...
CHAPTER 3: The Reovirus μ2 Protein Inhibits IFN Signaling Through a Novel
Mechanism Involving Nuclear Accumulation of Interferon Regulatory Factor‐9
Figure 3.1. T1L represses IFN‐induction of IRF7 and STAT1, but not ISG56.
Jennifer Michelle Zurney, 2008
3
Reovirus: New Insights for the Healthcare Professional: 2012 ...
interferon regulatory factor 3 (IRE-3) and nuclear factor kappa lightchain
enhancer of activated B cells (NF-kappa B) are required for the expression of IFN
-beta and the efficient induction of apoptosis in reovirus-infected cells. However,
it is not ...
4
Low Dose Tolerance Vaccine Platform,
Reovirus Protein Sigma ...
Effective treatments for multiple sclerosis (MS) are problematic due to its unknown etiology.
5
Hagan and Bruner's Microbiology and Infectious Diseases of ...
Canine Reovirus Infection Reovirus serotype 1 isolated from dogs with
respiratory signs of illness has produced interstitial pneumonia in naturally and
experimentally infected dogs (Lou and Ven- ner 1963). Inoculation of this isolate
into dogs ...
William Arthur Hagan, Dorsey William Bruner, John Francis Timoney, 1988
6
Cell Entry by Non-Enveloped Viruses
Reovirus infection elicits apoptosis of cultured cells and in vivo. Apoptosis
induction by reovirus requires activation of innate immune transcription factors
NF-kB and IRF-3 (Connolly et al. 2000; Hansberger et al. 2007; Holm et al. 2007)
(Fig. 8).
frequency in late summer, fall, and early winter (Gilbert et al. 1976; Palfi 1971;
Tani et al. 1995). Sample size, and reduced water flow at this time of year, should
also be considered when evaluating possible seasonal variations in reovirus ...
American Water Works Association, 2006
8
Immunoproteins—Advances in Research and Application: 2013 ...
“In another embodiment of the invention, reovirus is used to remove ras-mediated
neoplastic cells from a tissue or organ transplant prior to transplantation.
Because this method can be applied without regard to the type or age of the
transplant ...
9
The Mouse in Biomedical Research: Diseases
Chloroform inactivation of reovirus hemagglutinins. Can. Med. Assoc. J. 96, 597–
599. Rubin, D. H., Costello, T., Witzleben, C. L., and Greene M. I. (1987).
Transport of infectious reovirus into bile: Class II major histocompatibility
antigenbearing ...
10
Advances in DNA Research and Application: 2013 Edition
an adventitious agent is present in the reovirus preparation. Conversely, the
absence of any pathogenic effect validates the preparation as having no
detectable adventitious agents. “This method is also applicable to viruses or
other ...
10 NEWS ITEMS WHICH INCLUDE THE TERM «REOVIRUS»
Find out what the national and international press are talking about and how the term
reovirus is used in the context of the following news items.
The combination of intravenous Reolysin and gemcitabine induces …
The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated ... «7thSpace Interactive, Jul 15»
Oncolytic Virus Therapy Shows Promise in Patients With Pancreatic …
Reolysin is a proprietary variant of the reovirus (an acronym for “respiratory enteric orphan virus”), which is widely found in the environment. By adulthood, most ... «P&T Community, Jul 15»
Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA …
These data also suggest that the combination of PD-1 inhibition therapy with reovirus oncolytic/immunotherapy represents a readily translatable method to ... «Smarter Analyst, Jun 15»
Salmon farming and a court's decision
Piscine reovirus is a new disease first recognized in Atlantic salmon farms in Norway in 1999, then identified by research in 2010 as the causative agent for ... «Campbell River Mirror, Jun 15»
Oncolytic reovirus induces intracellular redistribution of Ras to …
Reovirus is a naturally oncolytic virus that preferentially replicates in Ras-transformed cells and is currently undergoing clinical trials as a cancer therapeutic. «Nature.com, May 15»
Oncolytics Biotech® Inc. Collaborators Present REOLYSIN …
The first abstract/poster titled "Combination therapy of reovirus and PD-1 blockade effectively established tumor control via innate and adaptive immune ... «PR Newswire, Apr 15»
Oncolytics Biotech scientists: With Reovirus Discovery, Cancer is …
The focal point among its discoveries is the reovirus, which is a type of brain cancer treatment. Called Reolysin, the company has already done the Phase I trials ... «Empire State Tribune, Apr 15»
A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs …
Oncolytics Biotech was founded in 1998 on discoveries made at the University of Calgary about the cancer-killing prowess of reovirus, a bug that most people ... «Forbes, Apr 15»
FDA Grants Reolysin Orphan Drug Designation for Ovarian Cancer
The FDA has granted an orphan drug designation to Reolysin (wild-type reovirus) for the treatment of patients with ovarian cancer, according to the developer of ... «OncLive, Feb 15»
Stock Insights on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)
The Company is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the ... «MicroCap Daily, Jan 15»
